INmune Bio Inc (INMB)
11.62
-0.22
(-1.86%)
USD |
NASDAQ |
May 01, 16:00
11.62
0.00 (0.00%)
After-Hours: 18:27
INmune Bio 1 Year Total Returns (Daily): 63.31% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 30, 2024 | 63.31% |
| April 29, 2024 | 62.34% |
| April 26, 2024 | 61.75% |
| April 25, 2024 | 53.76% |
| April 24, 2024 | 39.92% |
| April 23, 2024 | 37.96% |
| April 22, 2024 | 44.56% |
| April 19, 2024 | 0.72% |
| April 18, 2024 | 8.64% |
| April 17, 2024 | -0.24% |
| April 16, 2024 | 5.54% |
| April 15, 2024 | 10.50% |
| April 12, 2024 | 27.48% |
| April 11, 2024 | 36.75% |
| April 10, 2024 | 44.53% |
| April 09, 2024 | 54.39% |
| April 08, 2024 | 51.46% |
| April 05, 2024 | 59.08% |
| April 04, 2024 | 51.85% |
| April 03, 2024 | 46.16% |
| April 02, 2024 | 69.50% |
| April 01, 2024 | 78.33% |
| March 28, 2024 | 74.33% |
| March 27, 2024 | 73.32% |
| March 26, 2024 | 81.10% |
| Date | Value |
|---|---|
| March 25, 2024 | 78.51% |
| March 22, 2024 | 82.63% |
| March 21, 2024 | 73.00% |
| March 20, 2024 | 86.94% |
| March 19, 2024 | 66.26% |
| March 18, 2024 | 67.48% |
| March 15, 2024 | 62.41% |
| March 14, 2024 | 64.60% |
| March 13, 2024 | 65.41% |
| March 12, 2024 | 70.19% |
| March 11, 2024 | 69.61% |
| March 08, 2024 | 54.75% |
| March 07, 2024 | 50.06% |
| March 06, 2024 | 50.77% |
| March 05, 2024 | 39.09% |
| March 04, 2024 | 46.97% |
| March 01, 2024 | 32.80% |
| February 29, 2024 | 22.88% |
| February 28, 2024 | 25.21% |
| February 27, 2024 | 30.08% |
| February 26, 2024 | 45.99% |
| February 23, 2024 | 36.72% |
| February 22, 2024 | 40.10% |
| February 21, 2024 | 34.65% |
| February 20, 2024 | 37.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.41%
Minimum
Mar 18 2020
549.8%
Maximum
Mar 18 2021
34.57%
Average
5.41%
Median
Sep 28 2023
1 Year Total Returns (Daily) Benchmarks
| Biomarin Pharmaceutical Inc | -15.91% |
| Sarepta Therapeutics Inc | 3.09% |
| Dare Bioscience Inc | -69.25% |
| Zevra Therapeutics Inc | -15.19% |
| Kodiak Sciences Inc | -26.71% |